linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Mankind Pharma Ltd.
 
Source DateBoard Meeting DateDetails
09 Jan 202603 Feb 2026 Quarterly Results
27 Oct 202506 Nov 2025 Quarterly Results
14 Jul 202531 Jul 2025 Quarterly Results & Interim Dividend
08 May 202521 May 2025 Audited Results
13 Jan 202523 Jan 2025 Quarterly Results
25 Oct 202405 Nov 2024 Quarterly Results
17 Sep 202420 Sep 2024 Raising of Funds Inter alia, to consider and approve the raising of funds by way of issue of non-convertible debentures, commercial papers, other debt securities or any other security or any combination thereof for an amount as may be decided by the Board.
18 Jul 202431 Jul 2024 Quarterly Results
08 May 202415 May 2024 Audited Results Inter alia, to evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
16 Jan 202431 Jan 2024 Quarterly Results
11 Oct 202331 Oct 2023 Quarterly Results
18 Jul 202302 Aug 2023 Quarterly Results
23 May 202330 May 2023 Quarterly Results & Audited Results
Page 1 of 1
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.